Magazine Article | July 3, 2023

Cell & Gene Therapies Manufacturing Market Outlook

Source: Life Science Leader

By Industry Standard Research

In ISR’s Cell & Gene Therapies Manufacturing Market Outlook (2nd Edition) we asked respondents to rank their Top 3 satisfaction drivers regarding a CDMO’s performance in cell and/or gene manufacturing activities. The chart below shows the percentages of respondents who listed each driver in their Top 3, and the proportion of respondents who ranked the driver No. 1.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: